Antiverse
Health
· Headquartered in United Kingdom 🇬🇧
Track Antiverse
— get Health deals in free daily digest
Overview
Antiverse, a Cardiff-based biotech company, has raised £7 million in a Series A funding round led by Soulmates Ventures, with participation from several investors. This funding will help scale its AI-designed therapeutic antibody platform aimed at undruggable disease targets, particularly in cystic fibrosis research. Antiverse has partnered with the Cystic Fibrosis Foundation to develop novel antibodies targeting the CFTR protein, and aims to advance its internal drug pipeline and clinical testing by 2027.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Soulmates Ventures
Antiverse, a Cardiff-based biotech company, has raised £7 million in a Series A funding round led by Soulmates Ventures, with participation from several investors. This funding will help scale its AI-designed therapeutic antibody platform aimed at undruggable disease targets, particularly in cystic fibrosis research. Antiverse has partnered with the Cystic Fibrosis Foundation to develop novel antibodies targeting the CFTR protein, and aims to advance its internal drug pipeline and clinical testing by 2027.
More Health Deals
Market Map
View thousands of companies by category in our market map:
